In this engaging discussion, Sally Satel, a psychiatrist and senior fellow at the American Enterprise Institute, advocates for a legalized market for human organs, arguing it could address the critical organ shortage in the U.S. On the other hand, Jeremy Chapman, editor-in-chief of The Transplantation Journal, voices concerns about ethical implications and potential exploitation inherent in such a system. They explore contrasting views on donor safety, the effects of financial incentives, and insights from Iran's organ donation model, making for a thought-provoking debate.
